Vitamin D analogue + potent corticosteroid
Calcipotriol with betamethasone
Brand names: Dovobet, Enstilar, Wynzora
Adult dose
Dose: Apply OD to affected area; max 100g/week (gel/foam) for ≤4 weeks
Route: Topical
Frequency: OD
Clinical pearls
- NICE CG153: chronic plaque psoriasis 1st-line topical
- BAD psoriasis
- Foam (Enstilar) supports adherence; tapered descalation
Contraindications
- Erythrodermic / pustular psoriasis
- Calcium metabolism disorders
- Active skin infection
- Acne
- Rosacea
- Use on face / flexures (relative)
Side effects
- Local irritation
- Skin atrophy (steroid)
- Hypercalcaemia (extensive use)
- Telangiectasia
- Striae
- Folliculitis
Interactions
- Thiazides (hypercalcaemia)
Monitoring
- Skin response
- Calcium (extensive use)
- Steroid side-effects
Reference: BNF; NICE CG153; BAD; https://bnf.nice.org.uk/drugs/calcipotriol-with-betamethasone/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD